Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
We offer special corporate packages that can serve multiple employees in a single visit, making it both cost-effective and time-efficient
Ruxolitinib cream is currently the first Food and Drug Administration (FDA) approved vitiligo therapy for the topical treatment of non-segmental vitiligo in adults and pediatric patients over 12 years of age (119)
The most common allergic reaction is found in people allergic to eggs
Clinical trials with cagrilintide as monotherapy have shown modest weight loss (about 6-8% of body weight), showing the peptide has independent weight loss effect
People who experience chronic stress often see it first in their skin: breakouts, increased sensitivity, dullness
US$ 26.16
US$ 24.40
US$ 24.81
